Ejaculation

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2012-11-07
Clinical Trial Update: Assessment Of Safety Of UK-390,957 [Phase 2, Phase 3]
Pfizer's UK-390,957 safety assessment across Phase 2 and Phase 3 for ejaculation-related conditions has completed.